Dilovent Plus Tablet is used for asthma prevention.
Dilovent Plus Tablet side effects
Side Effects of Dilovent Plus are Nausea, Vomiting, Diarrhoea, Stomach upset, Skin rash, Flu-like symptoms, Dryness in mouth, Headache, Fatigue, Sleepiness, Rash, Urticaria, Itching, Breathing difficulty, Increased white blood cell count.
How to use Dilovent Plus Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dilovent Plus Tablet may be taken with or without food, but it is better to take it at a fixed time.
Dilovent Plus Tablet is a combination of three medicines: Montelukast, Levocetirizine and Acebrophylline. Montelukast is a leukotriene antagonist. It works by blocking the action of leukotriene, a chemical messenger. This reduces inflammation in the airways and nose, and improves symptoms of allergies. Levocetirizine is an antiallergic which relieves symptoms like runny nose, watery eyes and sneezing. Acebrophylline is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out.
In Depth Information on Dilovent Plus Tablet
Dilovent Plus Tablet related warnings
Special precautions for Dilovent Plus Tablet
Dilovent Plus Tablet may cause excessive drowsiness and calmness with alcohol.
Unknown. Human and animal studies are not available. Please consult your doctor.
No information is available on the use of Dilovent Plus Tablet during lactation. Please consult your doctor.
Dilovent Plus Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Dilovent Plus Tablet should be used with caution in patients with kidney disease. Dose adjustment of Dilovent Plus Tablet may be needed. Please consult your doctor.
Dilovent Plus Tablet should be used with caution in patients with liver disease. Dose adjustment of Dilovent Plus Tablet may be needed. Please consult your doctor.
No Patient Concerns found for this medicine
Information last updated by Dr. Varun Gupta, MD Pharmacology on 6th Sep 2018.